Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAC: Prevention of Asthma in Infants/Young Children
NCT00234390Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Nov 1998
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Budesonide with Placebo (2 arms). Primary endpoints: Number of symptom free days at 2 weeks, Number of days with no use of bronchodilator at 2 weeks and 1 more. Started Nov 1998; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00234390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234390.